Columbia Laboratories has acquired Molecular Profiles Ltd. for $16.7 million in cash and $8.3 million in Columbia common stock. The newly issued shares of Columbia stock are subject to a 12-month lock-up period, and Molecular Profiles’ chief executive officer and co-founder, Dr. Nikin Patel, will join Columbia’s board. Molecular Profiles recorded approximately $9 million in revenues in its fiscal year ending July 31, 2013. The price represents 10 to 11 times MP’s projected EBITDA for the fiscal...